DOLBY MEDICAL EBT TRUSTEE LIMITED


DOLBY MEDICAL EBT TRUSTEE LIMITED

Company Registration Number:
SC475115 (Scotland)

Unaudited statutory accounts for the year ended 31 March 2023

Period of accounts

Start date: 1 April 2022

End date: 31 March 2023

DOLBY MEDICAL EBT TRUSTEE LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2023

Directors report
Balance sheet
Additional notes
Balance sheet notes

DOLBY MEDICAL EBT TRUSTEE LIMITED

Directors' report period ended 31 March 2023

The directors present their report with the financial statements of the company for the period ended 31 March 2023

Principal activities of the company

Principal activitiesThe principal activity of the company is to act as trustee for an employee benefit trust (‘EBT’) on behalf of certain employees of Dolby Medical Limited.The company is a private company limited by shares, incorporated in the United Kingdom and domiciled in Scotland. Its registered office is Units 1-3, Block 5 Manor Farm Business Park, Manor Loan, Stirling, FK9 5QD.The company is a member of the group of companies headed by Phey Bidco Limited (‘the Group’). The principal activities of the group are the provision of materials, services and equipment to dental practices.

Additional information

Business reviewReview of the development and performance of the company The Company is a member of the group of companies headed by Phey Bidco Limited (‘the Group’). The principal activities of the Group is the provision of materials, services and equipment to dental practices. The Group is a leading supplier of dental and other medical consumables, materials, medical aesthetics and services (including the installation and servicing of specialised dental equipment), selling dental supplies and services to at least 8,000 dental practices and 3,000 aesthetic practices.Strategy and future outlook The company is expected to satisfy its remaining obligations to beneficiaries of the EBT in the forthcoming year. Financial review The company made no profit or loss for the years ended 31 March 2023 and 31 March 2022. Principal risks and uncertainties The company’s risks and uncertainties are integrated with the principal risks and uncertainties of the Group. Accordingly, the principal risks and uncertainties of Phey Bidco Limited, which includes those of the Company, are discussed in the Strategic report in the financial statements of Phey Bidco Limited which does not form part of this report. The consolidated financial statements of Phey Bidco Limited are publicly available and may be obtained from Phey Bidco Limited, 6 Perry Way, Witham, Essex, CM8 3SX, United Kingdom.



Directors

The directors shown below have held office during the whole of the period from
1 April 2022 to 31 March 2023

B Goodger
J E Deason


The director shown below has held office during the period of
1 April 2022 to 1 March 2023

GP Adams


The directors shown below have held office during the period of
1 April 2022 to 6 June 2022

T Riall
NK Pandya


Secretary J E Deason

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
18 April 2024

And signed on behalf of the board by:
Name: J E Deason
Status: Secretary

DOLBY MEDICAL EBT TRUSTEE LIMITED

Balance sheet

As at 31 March 2023

Notes 2023 2022


£

£
Current assets
Debtors: 3 1 1
Total current assets: 1 1
Net current assets (liabilities): 1 1
Total assets less current liabilities: 1 1
Total net assets (liabilities): 1 1
Capital and reserves
Called up share capital: 1 1
Total Shareholders' funds: 1 1

The notes form part of these financial statements

DOLBY MEDICAL EBT TRUSTEE LIMITED

Balance sheet statements

For the year ending 31 March 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen not to file a copy of the company's profit and loss account.

This report was approved by the board of directors on 18 April 2024
and signed on behalf of the board by:

Name: J E Deason
Status: Director

The notes form part of these financial statements

DOLBY MEDICAL EBT TRUSTEE LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Intangible fixed assets amortisation policy

    Financial instrumentsBasic financial assets and liabilities, including amounts owed by group undertakings and amounts owed to EBT beneficiaries, in accordance with section 11 and 12 of FRS 102 are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Such assets are subsequently carried at amortised cost using the effective interest method. At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in the income statement. If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been had the impairment not previously been recognised. The impairment reversal is recognised in the income statement.

    Valuation information and policy

    Carrying value of financial assets and liabilities At the end of each reporting period, the directors assess the carrying value of financial assets for objective evidence of impairment. In addition, where financial assets or liabilities constitute a financing arrangement, the value of the asset or liability is measured by reference to the present value of the estimated future cash flows. Both of these estimates require the future cash flows arising from the financial assets or liabilities to be estimated and an appropriate discount rate to be selected.

DOLBY MEDICAL EBT TRUSTEE LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

  • 2. Employees

    2023 2022
    Average number of employees during the period 0 0

DOLBY MEDICAL EBT TRUSTEE LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

3. Debtors

2023 2022
£ £
Other debtors 1 1
Total 1 1